organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 3123 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2019 | 22 |
Nanotoxicity and Risk Assessment |
|
| | | |
Modulation of the microbiota-gut-brain axis by bioactive food, prebiotics, and probiotics decelerates the course of Alzheimer's disease |
|
| | | |
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease |
|
| | | |
Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice |
|
| | | |
Roles of Gut Microbiota in Pathogenesis of Alzheimer’s Disease and Therapeutic Effects of Chinese Medicine |
|
| | | |
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine |
|
| | | |
Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies |
|
| | | |
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress? |
|
| | | |
Alternative Anti-Infective / Anti-Inflammatory Therapeutic Options for Fighting Alzheimer’s Disease |
|
| | | |
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? |
|
| | | |
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame? |
|
| | | |
Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (A?42) Peptide |
|
| | | |
Cell surface amyloid proteins of microorganisms: structure, properties and significance in medicine |
|
| | | |
The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure |
|
| | | |
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders |
|
| | | |
Age-related cerebral small vessel disease and inflammaging |
|
| | | |
Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases |
|
| | | |
Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease |
|
| | | |
Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD) |
|
| | | |
Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC |
|
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals